Merck & Co., Inc. news

   Watch this stock
Showing stories 11 - 20 of about 153   

Articles published

MRK 59.58 +0.60 (1.02%)
price chart
Can Newly Approved Gardasil 9 Boost Merck & Co.'s (MRK) Vaccine Business?
Merck & Co., Inc. (NYSE:MRK) received a dose of good news yesterday as the US Food and Drug Administration (FDA) announced approval of the company's Gardasil 9 vaccine for the prevention of certain cancers caused by nine types of Human ...
New HPV vaccine strengthens cancer protection  wwlp.com
FDA approves Gardasil 9 for prevention of certain cancers caused by five ...  FDA.gov
Related articles »  
Bristol-Myers Squibb, Merck & Co Drugs Show Promise In Early Trials For ...
Bristol-Myers Squibb Co (NYSE:BMY) and Merck & Co., Inc.'s (NYSE:MRK) respective cancer immunotherapies, Opdivo and Keytruda, showed promising results for the treatment of Hodgkin's lymphoma in two separate studies, researchers announced ...
Bristol-Myers Squibb partners Merck & Co for Hodgkin Therapy  The Westside Story
Merck immunotherapy drug shows promise against lymphoma: study  Reuters
Related articles »  
Merck & Co. Inc. (MRK) Closes 0.25% Down on the Day for December 16
Merck & Co. Inc. currently has a total float of 2.85 billion shares and moves 10.04 million a day, on average. The stock opened at $56.97 on December 16 and traded between a low of $56.78 and a high of $58.29.
Related articles »  
Buzz Stocks: Merck & Co., Inc., Bristol-Myers Squibb Co, and BlackBerry Ltd
Futures are pointed lower this morning, as traders digest disappointing economic data from overseas. Back on the homefront, specific equities in focus are pharmaceutical firms Merck & Co., Inc. (NYSE:MRK) and Bristol-Myers Squibb Co (NYSE:BMY), as well ...
Healthcare Sector Movers: Bristol-Myers Squibb Company (BMY), Merck & Co ...  WallStreet Scope
Related articles »  
Merck & Co. Inc. (MRK) Closes 2.34% Up on the Day for December 18
Merck & Co. Inc. currently has a total float of 2.85 billion shares and moves 9.98 million a day, on average. The stock opened at $58.59 on December 18 and traded between a low of $58.09 and a high of $58.98.
Moody's affirms Merck & Co.'s ratings; outlook stable
New York, December 08, 2014 -- Moody's Investors Service affirmed the ratings of Merck & Co., Inc. ("Merck").
Related articles »  
Merck & Co. Inc. (MRK) Closes 0.32% Down on the Day for December 11
Dow Jones component Merck & Co. Inc. (MRK) saw its stock move -0.32% to $59.34, representing a per-share move of $0.19, on volume of 11.11 million shares for Thursday.
Related articles »  
Merck & Co., Inc. (NYSE:MRK) Announces Early Findings
[The Fly] Merck & Co., Inc. (NYSE:MRK) announced early study findings demonstrating an overall response rate of 18.5% with KEYTRUDA, the company's anti-PD-1 therapy, as assessed by RECIST v1.1, central review in PD-L1 positive, advanced ...
Merck Reveals Data from Breast Cancer Study on Keytruda  Zacks.com
Related articles »  
Merck & Co. Inc. (MRK) Falls 3.02% for December 09
One of the S&P 500's big losers for Tuesday December 09 was Merck & Co. Inc. (MRK) . The company's stock fell 3.02% to $60.01 on volume of 18.64 million shares.
Related articles »  
Merck & Co. Inc. (MRK) Falls 2.73% for December 12
Merck & Co. Inc. is centered in Whitehouse Station, NJ, and has 76,000 employees. Today's trading day leaves the company with a market cap of $164.55 billion with a P/E Ratio of 32.3.
Related articles »